Cargando…
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Alzheimer’s disease (AD) is the most common form of dementia and may contribute to 60–70% of cases. Worldwide, around 50 million people suffer from dementia and the prediction is that the number will more than triple by 2050, as the population ages. Extracellular protein aggregation and plaque depos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961492/ https://www.ncbi.nlm.nih.gov/pubmed/36835301 http://dx.doi.org/10.3390/ijms24043895 |